Hospital confirms first UK case of extreme drug-resistant tuberculosis

With a treatment costing about £100,000 per person? In American dollars that's about...$200,000. But with the wonderful health care system we have here in the States we have nothing to worry about...oh wait...

http://www.guardian.co.uk/society/2008/mar/21/health

guardian.co.uk said:
Strains of TB which are resistant to the two main antibiotics used to treat it have been spreading across the globe and complicating treatment for some years. About 1% of the 8,497 cases reported in the UK in 2006 showed multiple drug resistance.

XDR-TB, however, is a new and still more alarming phenomenon, showing resistance to both first and second-line drugs. Treatment takes 12 to 18 months and costs more than £100,000 a patient. An outbreak would place a huge financial burden on local health authorities.

The 'White Death': An old threat returns

Tuberculosis, once known as the White Death, ceased to be a big threat to the UK after the discovery of antibiotics. But the disease that killed Keats and at least two of the Brontë sisters has appeared in a new, deadly form with the identification of a case that appears resistant to most known drugs.
 
Telperion said:
Tuberculosis, once known as the White Death, ceased to be a big threat to the UK after the discovery of antibiotics. But the disease that killed Keats and at least two of the Brontë sisters has appeared in a new, deadly form with the identification of a case that appears resistant to most known drugs.
While bacteria like those that cause tuberculosis can mutate to forms which are impervious to pharmaceutical antibiotics, they remain quite vulnerable to nanoparticle silver sols. This is information that you are not freely offered in the media.

Silver works catalytically on bacteria and not chemically, as do antibiotics. Bacteria can therefore never develop resistance to silver. American Biotech Labs currently holds two US Patents for their novel method of generating a nanoparticle silver sol with consistent elemental (not ionic) particle size throughout the solution (5 - 7 nm) and extremely high bioavailability. In 2006, the USPTO granted them their third patent. This time the patent was for the actual silver particle itself... a first ever.

In this patent is described the clinical procedures used to define the killing abilities of this substance on a large variety of pathogens responsible for many of the current diseases which afflict humanity. One such series of tests focused on tuberculosis:

9. Evidence of Efficacy of 10 ppm Silver Against Tuberculosis Bacteria

A. Purpose

The purpose of this example is to demonstrate the efficacy of a silver composition of the present invention against the bacteria that cause tuberculosis. This example describes the procedures for evaluation of the present invention for tuberculocidal efficacy. The methodology is based on the Tuberculocidal Activity Test Method as accepted by the EPA on Dec. 11, 1985. [Refer to United States Environmental Protection Agency, 1986. Office of Pesticides and Toxic Substances. Data Call-In Notice for Tubercuolocidal Effectiveness Data for All Antimicrobial Pesticides with Tuberculocidal Claims. (Received Jun. 13, 1986).

Snip -

D. Conclusions

The use of silver compositions of the present invention is effective against tuberculosis bacteria. A method comprising the step of administering silver compositions of the present invention is effective against tuberculosis organisms.

http://tinyurl.com/yceqd6
Hospital trials in several different African countries have affected full quick tuberculosis cures with the exclusive use of what is marketed in the US as a nutritional supplement. That information can be found at my website, linked over on the left in this post. Look under the clinical Studies and Congressional Testimony page links there. The Appendix section to the Congressional Testimony contains some interesting documents with regard to the African malaria studies also. There are now over 1100 documented African full malaria cures. All of them in under one week, in final stage patients, for less than $10.00 treatment cost per patient.

Knowing the ban on advertising at SOTT, I am always reluctant to post information about this product, since I am aggressively involved in its distribution, but I feel strongly that there needs to be much more public education about the availability of these products. You do not need to acquire them through our project, as they are available at many US health food and vitamin shops marketed under the retail brand name Silver Biotics.

I would suggest that if you are not familiar with this new class of silver products that you visit our website and educate yourself. There is very little to fear from tuberculosis, and a great many other deadly pathogens, if you are aware of your options.

Knowledge protects.
 
Back
Top Bottom